These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24892465)

  • 1. [Statins for primary prevention: are the guidelines in need of improvement? - Preventive pharmacotherapy: indication has to be adapted individually].
    Siepmann T
    Dtsch Med Wochenschr; 2014 Jun; 139(24):1284. PubMed ID: 24892465
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolving Approaches for Statins in Primary Prevention: Progress, but Questions Remain.
    Navar AM; Peterson ED
    JAMA; 2016 Nov; 316(19):1981-1983. PubMed ID: 27838704
    [No Abstract]   [Full Text] [Related]  

  • 3. Statins: new American guidelines for prevention of cardiovascular disease.
    Ridker PM; Cook NR
    Lancet; 2013 Nov; 382(9907):1762-5. PubMed ID: 24268611
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins for primary prevention in people with a 10% 10-year cardiovascular risk: too much medicine too soon?
    Yerrakalva D; Griffin SJ
    Br J Gen Pract; 2017 Jan; 67(654):40-41. PubMed ID: 28034950
    [No Abstract]   [Full Text] [Related]  

  • 5. New Cholesterol Guidelines Personalize Risk and Add Treatments.
    Abbasi J
    JAMA; 2019 Feb; 321(8):731-732. PubMed ID: 30725107
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins, risk assessment, and the new American prevention guidelines.
    Lloyd-Jones DM; Goff D; Stone NJ
    Lancet; 2014 Feb; 383(9917):600-2. PubMed ID: 24315619
    [No Abstract]   [Full Text] [Related]  

  • 7. ACP Journal Club. ACC/AHA, Adult Treatment Panel III, and ESC guidelines overestimated risk for CVD in older adults.
    Vaishnava P; Eagle KA
    Ann Intern Med; 2014 Aug; 161(4):JC13. PubMed ID: 25133380
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.
    Robson J
    Heart; 2008 Oct; 94(10):1331-2. PubMed ID: 18701534
    [No Abstract]   [Full Text] [Related]  

  • 9. Questioning the benefits of statins.
    Mazowita G
    CMAJ; 2005 Nov; 173(10):1210; author reply 1210. PubMed ID: 16275979
    [No Abstract]   [Full Text] [Related]  

  • 10. NICE guidelines could put 12 million UK adults on statins.
    Hawkes N
    BMJ; 2017 Aug; 358():j3674. PubMed ID: 28765117
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins: new US guideline sparks controversy.
    Lancet; 2013 Nov; 382(9906):1680. PubMed ID: 24267985
    [No Abstract]   [Full Text] [Related]  

  • 12. Statins in the elderly: what evidence of their benefit in prevention?
    Steg PG; Tissot CM
    Arch Cardiovasc Dis; 2010 Feb; 103(2):61-5. PubMed ID: 20226424
    [No Abstract]   [Full Text] [Related]  

  • 13. NICE sticks to its advice to drop threshold for prescribing statins.
    Hawkes N
    BMJ; 2014 Jul; 349():g4694. PubMed ID: 25037780
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary: Controversies in NICE guidance on lipid modification for the prevention of cardiovascular disease.
    Cappuccio FP
    BMJ; 2008 May; 336(7655):1248-9. PubMed ID: 18511801
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance.
    Cooper A; O'Flynn N;
    BMJ; 2008 May; 336(7655):1246-8. PubMed ID: 18511800
    [No Abstract]   [Full Text] [Related]  

  • 16. Statins and cataracts: reverse causality?
    Spence JD
    Can J Cardiol; 2015 May; 31(5):691.e11. PubMed ID: 25795104
    [No Abstract]   [Full Text] [Related]  

  • 17. Statins and cancer survivors: the need for structured guidelines.
    Almuwaqqat Z; Hung O; Parashar S
    Future Cardiol; 2018 Jan; 14(1):5-8. PubMed ID: 29168650
    [No Abstract]   [Full Text] [Related]  

  • 18. Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence.
    Gurwitz JH; Go AS; Fortmann SP
    JAMA; 2016 Nov; 316(19):1971-1972. PubMed ID: 27838724
    [No Abstract]   [Full Text] [Related]  

  • 19. Some question use of statins to reduce cardiovascular risks in healthy women.
    Mitka M
    JAMA; 2012 Mar; 307(9):893-4. PubMed ID: 22396503
    [No Abstract]   [Full Text] [Related]  

  • 20. The new cholesterol and blood pressure guidelines: perspective on the path forward.
    Krumholz HM
    JAMA; 2014 Apr; 311(14):1403-5. PubMed ID: 24682222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.